Anoro Ellipta is a brand-name inhaler that’s prescribed for long-term chronic obstructive pulmonary disease (COPD) treatment. Anoro Ellipta contains the active ingredients vilanterol and ...

Anoro Ellipta is supplied as a disposable light grey and red plastic inhaler containing two double-foil blister strips, each with 30 blisters containing powder intended for oral inhalation only.

The U.S. Food and Drug Administration have approved GlaxoSmithKline's Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive pulmonary disease.

GSK Study Demonstrates Superiority of Anoro Ellipta to Stiolto Respimat in Improving Lung Function in Chronic Obstructive Pulmonary Disease November 01, 2017 07:00 AM Eastern Daylight Time ...